Jounce Therapeutics (NASDAQ:JNCE) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Jounce Therapeutics missed estimated earnings by 26.32%, reporting an EPS of $-0.72 versus an estimate of $-0.57.
Revenue was down $1.54 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.27 which was followed by a 4.16% drop in the share price the next day.
Here's a look at Jounce Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.44 | -0.36 | -0.41 |
| EPS Actual | -0.59 | -0.59 | -0.08 | -0.58 |
| Revenue Estimate | 12.31M | 6.48M | 8.18M | 11.81M |
| Revenue Actual | 0 | 0 | 25.37M | 1.54M |
To track all earnings releases for Jounce Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
